Find a Pharmacy
Vertice Login
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Advocacy & Compliance

Healthesystems’ Advocacy & Compliance experts are essential in the management of pharmacy and ancillary benefits for our clients. By tracking and influencing regulatory activity, our team stays  ahead of evolving trends and identifies opportunities to advocate on behalf of our clients, their injured workers, and the broader industry.

The Advocacy & 
Compliance Team

Monitors and reports on proposed and pending regulatory changes that impact workers' comp, helping shape effective program strategies

Advocates for fair and balanced public policy through proactive engagement with regulators, customers, and other stakeholders throughout the rulemaking lifecycle

Supports operational compliance by providing guidance to internal stakeholders and external partners during the implementation of new regulatory changes

Regulatory Recap

A weekly e-newsletter informed by the Advocacy & Compliance team to help keep our clients and industry contacts in the know on the latest legislation and policy updates impacting workers’ comp.
Subscribe
Spotlight

Pennsylvania Advisory Council Signals Legislative Attention Needed on Topical Cap

Senate Bill 1215 was discussed, and it appears unlikely the proposed reimbursement caps will be passed.
Read More →
April 20, 2026
Spotlight

Louisiana Bill Would Remove Prescription Drugs from MTS Authorization and Appeals

Louisiana introduced a bill that would remove prescribed drugs from the Medical Treatment Schedule (MTS) authorization timelines and Medical Director appeal process under the workers’ compensation law.
Read More →
April 6, 2026
Spotlight

Oklahoma Bills Would Create Conflicts for Workers’ Compensation Pharmacy

Two Oklahoma bills heading for House consideration would establish a NADAC based reimbursement floor, minimum dispensing fees, and a shortened 30 day payment timeframe.
Read More →
March 30, 2026

California P&T Committee Recommends Formulary Updates

The committee issued new recommendations related to 300 mg ibuprofen, gabapentin and pregabalin, cyclobenzaprine, and tizanidine.
Read More →
April 20, 2026

Colorado Gathers Stakeholder Feedback on Medical Fee Schedule

Matters discussed included physician dispensing, missed appointment fees, passive therapy utilization, and interpreter bill denials.
Read More →
April 20, 2026

Texas DWC Requests Legislative Recommendations

Stakeholders may send specific legislative recommendations to the DWC, if they are supported by data, and with relevant background or context.
Read More →
April 20, 2026

Virginia Enacts Heat Illness Prevention Standards

The Safety and Health Codes Board, in consultation with the DOL, must develop and adopt heat illness prevention standards by May 1, 2028.
Read More →
April 20, 2026

WCRI Reports on Air Ambulances

About 1 in 100 workers injured in rural areas with more than seven days of lost time had air ambulance services.
Read More →
April 20, 2026

NCCI Issues First in a Series of Workplace Violence Reports

Workplace assaults have increased at a rate of 5.3% per year from 2011-2022, primarily impacting health care and social assistance workers.
Read More →
April 20, 2026
1 2 3 50

Subscribe to Regulatory Recap

Get weekly legislation & policy updates straight to your inbox.
regulatory recap newsletter image
hello world!

 Further resources you may be interested in

Additional articles and updates from Healthesystems related to policy shaping workers’ comp.

Pennsylvania Proposes Reimbursement Caps for Compounds and Topicals

The bill would create a $400, 30-day supply cap for compound drugs.
Read More

New Jersey Proposes Marijuana Reimbursement in Workers’ Comp and Group Health

Companion bills S3984 and A1023 would require health insurance coverage for the medical use of cannabis under certain circumstances.
Read More

Florida Appeals Court Rules in Favor of Carriers and Employers on Physician-Dispensed Drugs

While injured workers have an absolute choice over their pharmacist, physicians are not considered pharmacists and therefore not entitled to reimbursement.
Read More

WCRI Publishes National Repository on Prescription Drug Regulations

While the report addresses multiple topics, a significant focus was given to the expanding role of pharmacists as a healthcare provider.
Read More

Expert Q&A: What Utah’s AI Prescription Renewal Pilot Signals About the Evolving Role of AI in Treatment Decisions

Utah’s prescription renewal pilot is a groundbreaking use case for AI in healthcare. What are the potential benefits and pitfalls?
Read More

Inside Medical Experience: Signals, Trends, and System Impact

Healthe’s VP of Industry and State Affairs, Sandy Shtab, joins a panel presentation at the Pennsylvania/Delawaare 2026 Workers’ Compensation Symposium.
Read More
1 2 3 50
Back to Top
lockmap-markermagnifiercrossmenuarrow-rightcross-circle